# Track A non-empirical matrix adjudication

Controller: #408

## Decision

**PASS — advance only to a separately reviewed prospective empirical protocol proposal.**

This adjudication closes the bounded structural-matrix gate for `PDMAL_TOPOLOGY_ROBUSTNESS_PROFILE_V1`. It does not freeze an empirical candidate, authorize collection, establish topology superiority or empirical robustness, relabel the neutral reference algorithm as DGAF, or change High-Assurance status.

## Exact evidence boundary

- Workload architecture merge: `5e4f00a065c00cefec0b3a79c32b88a5f36a55c2`
- Track A profile merge: `b1e333ee9f9e0a4da78788e5ff019603296888eb`
- Track A P-30/P-11 qualification merge: `647f612a2412818dca0d632229f352e857e1187e`
- Exact profile head: `9340081997bcc59e831e8b47312efe344b6bc4dd`
- Exact-head workflows: **20/20 passed**
- Structural workflow run: `34189626294`
- Retained artifact: `10041800252`
- Archive digest: `sha256:629ee0be7a48606685f2452800ab4e482611fb45f7268d881e934488e1c1c1d5`
- Extracted payload SHA-256: `e51497d150530d983f94002d23a21608be9135ca300d29a47b126ed184fdc489`

## Structural inspection

- 90 expected cells, 90 completed cells, and 90 unique seed × topology × failure-count cells.
- Two diagnostic-only seeds × five topologies × nine failure counts.
- Zero recovery-hash mismatches.
- Zero no-failure phase-hash mismatches.
- All 80 positive-failure cells changed their failure-active update hash.
- Seven topology fingerprints: one each for ring, PDMAL and complete; two each for seed-specific random-regular and small-world graphs.
- No prohibited efficacy endpoint or DGAF-treatment token is present in the retained payload.

These findings show matrix completeness, deterministic reproduction, phase sensitivity and recovery identity. They do not measure performance.

## Remaining Track A gates

The next permissible artifact is a prospective empirical protocol proposal containing all of the following before any runner or authorization request:

1. research question and directional hypothesis;
2. exact neutral treatment and named comparators;
3. primary endpoint and estimand;
4. fixed topology × failure matrix;
5. fresh seed rule and collision check;
6. sample-size rationale and prospective QC rule;
7. locked analysis and multiplicity policy;
8. blinding, custody and unblinding sequence;
9. separately reviewed runner implementation;
10. separate exact-commit collection authorization.

`SCIENTIFIC_N_INCREMENT = 0`

`TRACK_A_EMPIRICAL_EXECUTION = NOT_AUTHORIZED`

`TRACK_A_FREEZE = NOT_ESTABLISHED`

`HIGH_ASSURANCE = NOT_AUTHORIZED / N=0`
